Schedule 13G ownership disclosure

Janux Therapeutics Inc

Security class unavailable · CUSIP: 47103J105

Event date: 2023-05-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000921895-23-001386
Form type
SC 13G
Filer
BIOTECHNOLOGY VALUE FUND L P
CIK
CIK 918923
Filed
May 30, 2023
Reporting period
May 17, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub